Medical science is on the verge of success in the treatment of the deadly coronavirus. Today the vaccine against the highly resistant deadly coronavirus is going to be applied to the human body.
The vaccine will be administered to humans in the UK on Thursday. If it succeeds, the world will have a big shield to fight this irresistible virus.
A team of scientists led by Professor Sarah Catherine Gilbert, an experienced vaccinator at Oxford University in the United Kingdom, worked tirelessly day and night to develop this vaccine for coronavirus. They plan to make 1 million doses of this vaccine by September.
Earlier, he made a dose of 3 liters to be applied experimentally to the human body. The volunteers who will take part in this test are also ready. The coronavirus vaccine will be administered to 500 healthy people between the ages of 18 and 55 by next May.
If they succeed in the experimental application, they will gradually prepare doses of 50 liters, 100 liters, 200 liters and even 2000 liters. Because, billions of people around the world will need this vaccine. They are eagerly awaiting the coronavirus vaccine.
A number of institutions in the UK and other countries have already signed agreements with Oxford University on the vaccine. If successful, they will also start producing this vaccine. The agreement is with the Seram Institute, an institution in our neighboring country India. Ginger Punawala, the company’s executive officer, said they would not release the vaccine to businesses. Because, now is not the time to do business.
British Health Minister Matt Hancock on Wednesday confirmed the experimental application of vaccines made by scientists at Oxford University.
However, scientists cannot say for sure whether such a vaccine will work in the human body. But scientists at Oxford University are 80 percent optimistic about its success. There is, of course, reason behind their optimism. That is, the team includes scientists who have developed vaccines for the Mars and Ebola viruses. They have extensive experience in developing rapid vaccines.
It remains to be seen whether the successful application of this coronavirus vaccine, created with that experience, can bring relief to 700 million people around the world.
References: BBC, Daily Mail, The Sun and India Today